All sectors of life sciences are growing, but R&D continues to outperform supply markets and manufacturing at a significant rate. The key driver to this growth has been innovation in biotechnology. Resulting in an immeasurable discovery landscape. This includes new and old therapeutics, diagnostics and pharma’s who rely on supply and manufacturing to support their research.
Research-grade material standards are still at bare minimum and consistency is at a record low. Innovation needs to catch up on the commercial biotech side, so that R&D companies can rely on partners that move at a proportionate pace.
kbDNA is promoting this change by employing new production technologies, standardizing data with material science and developing product solutions that enable researchers.